NFlection Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- NFlection Therapeutics's estimated annual revenue is currently $542.5k per year.
- NFlection Therapeutics's estimated revenue per employee is $77,500
Employee Data
- NFlection Therapeutics has 7 Employees.
- NFlection Therapeutics grew their employee count by -30% last year.
NFlection Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CFO | Reveal Email/Phone |
3 | Director Clinical Operations | Reveal Email/Phone |
4 | Chief Operating Officer | Reveal Email/Phone |
5 | Chief Medical Officer | Reveal Email/Phone |
NFlection Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is NFlection Therapeutics?
NFlection is a biopharmaceutical company focused on the development of novel therapies to address the needs of patients with neurofibromatosis type 1, immunosuppressant-mediated squamous cell carcinoma, and congenital birthmarks such as keratinocytic epidermal nevi. To address these rare disorders, which are also referred to as RASopathies because they are driven by the aberrant activation of the Ras/Raf/MEK/ERK pathway, we are developing first-in-class MEK (mitogen-activated protein kinase kinase) inhibitors as topical treatments.
keywords:N/AN/A
Total Funding
7
Number of Employees
$542.5k
Revenue (est)
-30%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.8M | 7 | -22% | N/A |
#2 | $0.1M | 7 | 0% | $25M |
#3 | $0.5M | 7 | N/A | N/A |
#4 | $0.5M | 7 | N/A | N/A |
#5 | $0.1M | 7 | 0% | $3.1M |